Response to Haiman, Kote-Jarai, Darst et al

Tyler M Seibert^{1

2

3

4}, Meghana S Pagadala^{1

5

6}, Julie Lynch^{7

8}, Roshan Karunamuni², Hannah Carter⁹, Brent S Rose^{1

2

10}, Richard L Hauger^{1

11

12}

Affiliations

¹ Research Service, VA San Diego Healthcare System, San Diego, CA, USA.
² Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA.
³ Department of Radiology, University of California San Diego, La Jolla, CA, USA.
⁴ Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
⁵ Medical Scientist Training Program, University of California San Diego, La Jolla, CA, USA.
⁶ Biomedical Science Program, University of California San Diego, La Jolla, CA, USA.
⁷ VA Informatics and Computing Infrastructure, VA Salt Lake City Healthcare System (VINCI), Salt Lake City, UT, USA.
⁸ Department of Internal Medicine, Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA.
⁹ Department of Medicine, University of California San Diego, La Jolla, CA, USA.
¹⁰ Department of Urology, University of California San Diego, La Jolla, CA, USA.
¹¹ Center for Behavioral Genetics of Aging, University of California San Diego, La Jolla, CA, USA.
¹² Center of Excellence for Stress and Mental Health (CESAMH), VA San Diego Healthcare System, San Diego, CA, USA.

PMID: 36629482
PMCID: PMC9996213
DOI: 10.1093/jnci/djad006

Comment

Response to Haiman, Kote-Jarai, Darst et al

Tyler M Seibert et al. J Natl Cancer Inst. 2023.

. 2023 Mar 9;115(3):343-344.

doi: 10.1093/jnci/djad006.

Authors

Tyler M Seibert^{1

2

3

4}, Meghana S Pagadala^{1

5

6}, Julie Lynch^{7

8}, Roshan Karunamuni², Hannah Carter⁹, Brent S Rose^{1

2

10}, Richard L Hauger^{1

11

12}

Affiliations

¹ Research Service, VA San Diego Healthcare System, San Diego, CA, USA.
² Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, CA, USA.
³ Department of Radiology, University of California San Diego, La Jolla, CA, USA.
⁴ Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
⁵ Medical Scientist Training Program, University of California San Diego, La Jolla, CA, USA.
⁶ Biomedical Science Program, University of California San Diego, La Jolla, CA, USA.
⁷ VA Informatics and Computing Infrastructure, VA Salt Lake City Healthcare System (VINCI), Salt Lake City, UT, USA.
⁸ Department of Internal Medicine, Division of Epidemiology, University of Utah School of Medicine, Salt Lake City, UT, USA.
⁹ Department of Medicine, University of California San Diego, La Jolla, CA, USA.
¹⁰ Department of Urology, University of California San Diego, La Jolla, CA, USA.
¹¹ Center for Behavioral Genetics of Aging, University of California San Diego, La Jolla, CA, USA.
¹² Center of Excellence for Stress and Mental Health (CESAMH), VA San Diego Healthcare System, San Diego, CA, USA.

PMID: 36629482
PMCID: PMC9996213
DOI: 10.1093/jnci/djad006

No abstract available

PubMed Disclaimer

Comment on

RE: Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program.
Haiman CA, Kote-Jarai Z, Darst BF, Conti DV. Haiman CA, et al. J Natl Cancer Inst. 2023 Mar 9;115(3):341-342. doi: 10.1093/jnci/djad005. J Natl Cancer Inst. 2023. PMID: 36629487 Free PMC article. No abstract available.

References

1. Moses KA, Sprenkle PC, Box G, et al. NCCN Guidelines Prostate Cancer Early Detection Version 1.2022. 69; 2022. https://www.nccn.org/guidelines/guidelines-detail?category=2&id=1460. Accessed October 12, 2021.
1. Dess RT, Hartman HE, Mahal BA, et al. Association of Black race with prostate cancer-specific and other-cause mortality. JAMA Oncol. 2019;5(7):975-983. - PMC - PubMed
1. Mahal BA, Aizer AA, Ziehr DR, et al. Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups. Urology. 2014;84(2):386-392. - PubMed
1. Huynh-Le M-P, Karunamuni R, Fan CC, et al. ; for the UKGPCS Collaborators. Prostate cancer risk stratification improvement across multiple ancestries with new polygenic hazard score. Prostate Cancer Prostatic Dis. 2022;25(4):755-761. doi: 10.1038/s41391-022-00497-7. - DOI - PMC - PubMed
1. Chen F, Darst BF, Madduri RK, et al. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: a meta-analysis within diverse populations. eLife. 2022;11:e78304. - PMC - PubMed

Publication types

Actions
Actions
Actions

Grants and funding

R01 AG050595/AG/NIA NIH HHS/United States

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Response to Haiman, Kote-Jarai, Darst et al

Affiliations

Response to Haiman, Kote-Jarai, Darst et al

Authors

Affiliations

Comment on

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources